Gansu, China

Meijuan Song

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Lanzhou University. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meijuan Song. Retrieved from https://idiyas.com/inventor/meijuan-song

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Meijuan Song: Innovator in Fusion Protein Technology

Introduction

Meijuan Song is a notable inventor based in Gansu, China. She has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. Her work focuses on innovative solutions for medical applications, especially in treating central nervous system inflammations.

Latest Patents

Meijuan Song holds a patent for a fusion protein for alpha-melanocyte stimulating hormone. This fusion protein includes a protein transduction domain, human serum albumin, and alpha-melanocyte stimulating hormone. The patent also details a method for preparing this fusion protein and its use in inhibiting or treating central nervous system inflammations.

Career Highlights

Meijuan Song is affiliated with Lanzhou University, where she conducts her research and development activities. Her work has garnered attention for its potential impact on medical treatments and therapeutic approaches.

Collaborations

Meijuan collaborates with esteemed colleagues, including Hongyu Li and Meizhu Wang, who contribute to her research endeavors.

Conclusion

Meijuan Song's innovative work in fusion protein technology exemplifies the advancements being made in biotechnology. Her contributions are paving the way for new treatments in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…